C07K 2317/526
Ch3 domain
Official title: CH3 domain
C07K2317/526 (Ch3 domain) appears on 1,087 US grants and 2,448 published applications in this corpus.
Search patents in C07K- Granted patents
- 1,087
- Published applications
- 2,448
- Assignees
- 660
- Inventors
- 4,119
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 6 |
| 2008 | 0 | 2 |
| 2009 | 0 | 11 |
| 2010 | 3 | 17 |
| 2011 | 3 | 19 |
| 2012 | 7 | 20 |
| 2013 | 11 | 47 |
| 2014 | 25 | 46 |
| 2015 | 32 | 61 |
| 2016 | 39 | 126 |
| 2017 | 59 | 126 |
| 2018 | 48 | 141 |
| 2019 | 81 | 145 |
| 2020 | 96 | 201 |
| 2021 | 100 | 236 |
| 2022 | 113 | 256 |
| 2023 | 99 | 231 |
| 2024 | 120 | 289 |
| 2025 | 157 | 264 |
| 2026 | 91 | 199 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof29 Sep 2026US 12,747,279 B2Abelzeta Inc.
- Bispecific antibody simultaneously binding to interleukin-4 receptor alpha subunit and interleukin-5 receptor alpha subunit, encoding nucleic acids thereof and methods of use thereof for treatment29 Sep 2026US 12,747,297 B2Ajou University Industry-Academic Cooperation Foundation
- Methods and antibody compositions for tumor treatment29 Sep 2026US 12,747,300 B2Regeneron Pharmaceuticals, Inc.
- Immunoglobulin variants15 Sep 2026US 12,735,502 B2Novartis AG
- Compositions and methods for inhibiting T cell exhaustion8 Sep 2026US 12,729,245 B2The Board of Trustees of the Leland Stanford Junior University
- Cd3 binding molecules8 Oct 2026US 2026/0308254 A1Merus N.V.
- Agents that bind to cd16a and uses thereof8 Oct 2026US 2026/0308258 A1Avantgen, Inc.
- Il12rb2 binding molecules and methods of use8 Oct 2026US 2026/0308265 A1Synthekine, Inc.
- Dual transporters and methods of use8 Oct 2026US 2026/0308269 A1Denali Therapeutics Inc.
- Engineered Antibodies and Uses Thereof8 Oct 2026US 2026/0308277 A1Invitrogen Bioservices India Private Limited
Most cited
By later US patents
- Method for making heteromultimeric polypeptides932US 5,731,168 AGenentech, Inc. · 1998
- Knobs and holes heteromeric polypeptides342US 7,695,936 B2Genentech, Inc. · 2010
- Method for making heteromultimeric polypeptides340US 5,821,333 AGenetech, Inc. · 1998
- Method for making heteromultimeric polypeptides301US 5,807,706 AGenentech, Inc. · 1998
- Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects301US 8,592,562 B2Amgen Inc. · 2013